A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study co-author Dr. Vinod Balachandran talks about the impact on future cancer care.

A number of clinical trials are looking at vaccines as a breast cancer treatment option and at biomarkers as a way to guide treatment decisions. Vaccines for Breast Cancer ...

We could be on the verge of a major cancer treatment breakthrough, with a new vaccine shown to completely obliterate pancreatic cancer cells in preclinical trials. This paves the way for it to ...

An experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based therapeutic cancer vaccine autogene cevumeran continues to show potential to stimulate an immune response ...

More information: Vvax001, a therapeutic vaccine for patients with HPV16-positive high-grade cervical intraepithelial ...

The American Cancer Society estimates that about 67,440 Americans (34,950 men and 32,490 women) will be diagnosed with ...

Cancer vaccines have been a tantalizing idea for decades, but the vast complexity of the human immune system has posed significant challenges. Now, technological advances like rapid DNA sequencing ...

In August, BioNTech announced a phase 1 global trial to study BNT116 — a vaccine to treat non–small cell lung cancer (NSCLC). BNT116, like mRNA-4157, targets specific antigens in the lung ...

Early trials are meant to test whether or not a treatment is feasible — in this case, if an mRNA vaccine for pancreatic cancer could produce durable T cells. The findings suggest that it can.

A vaccine to prevent breast cancer is showing good results, and moving into the next stage of clinical trials. “This vaccine is designed eventually to prevent breast cancer,” said Amit Kumar ...

Broader-based vaccines have already shown some promise in boosting CAR-T therapy for solid tumors. Cancer vaccines may also be able to help train the immune system to recognize and kill cancers ...

The American Cancer Society estimates that about 67,440 Americans (34,950 men and 32,490 women) will be diagnosed with pancreatic cancer this year. Of those, about 51,980 people (27,050 men and ...